Novus and Verenium to launch next generation phytase
Animal health and nutrition products manufacturer Novus International and biotechnology company Verenium Corporation have selected a next-generation phytase as the first enzyme candidate from the two companies' strategic collaboration to advance toward commercialization.
The companies embarked on a strategic partnership in June of last year to develop a suite of new enzyme products from Verenium's late-stage pipeline in the animal nutrition and health area globally.
"This partnership has enabled us to create enzyme solutions for nutritionists, producers and others who want to optimize nutrition. This product is geared toward use in poultry, pork and aquaculture product," said Novus International President and CEO Thad Simons.
"This product is indicative of significant progress we've made so far in our partnership with Novus, having exceeded important technical milestones ahead of schedule," said James Levine, President and CEO at Verenium
"Looking ahead, we anticipate advancing additional product candidates and commercializing a suite of differentiated enzyme products that deliver superior performance and make a significant impact on the animal health and nutrition industry."
In addition to the next-generation phytase, the collaboration also has three additional products in late-stage development targeted at this market.
To comment, login here
Or register to be able to comment.